Defactinib

The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Eli Lilly
GSK
AstraZeneca
Shire
Celladon
Takeda
Merck
Roche
Verastem
evacetrapib
Breo Ellipta
brodalumab
selumetinib
SHP625
Mydicar
Alisertib
suggammadex
sembragiline
Defactinib
Verastem concedes lead drug flopped in PhII mesothelioma study
Fierce Biotech
Mon, 09/28/15 - 08:21 am
Verastem
mesothelioma
Defactinib
clinical trials
Verastem Initiates Phase 2 Trial of Defactinib in Lung Cancer
Yahoo
Thu, 09/26/13 - 09:48 am
Defactinib
Verastem
non-small cell lung cancer
Verastem Reports on Ongoing Trials at Cancer Advance at Harvard Medical School
Yahoo
Fri, 09/20/13 - 10:18 am
clinical trials
Harvard
Verastem
Defactinib
mesothelioma
Verastem: An Attractive Long-Term Investment In The Cancer Stem Cell Space
Seeking Alpha
Tue, 09/17/13 - 09:54 am
stem cells
cancer
Verastem
VS-4718
Defactinib
VS-5584